PT1056467E - Processo para o tratamento de doencas ou perturbacoes do ouvido interno - Google Patents

Processo para o tratamento de doencas ou perturbacoes do ouvido interno

Info

Publication number
PT1056467E
PT1056467E PT99910259T PT99910259T PT1056467E PT 1056467 E PT1056467 E PT 1056467E PT 99910259 T PT99910259 T PT 99910259T PT 99910259 T PT99910259 T PT 99910259T PT 1056467 E PT1056467 E PT 1056467E
Authority
PT
Portugal
Prior art keywords
inner ear
sensory cells
diseases
treatment
cells
Prior art date
Application number
PT99910259T
Other languages
English (en)
Portuguese (pt)
Inventor
Hubert Loewenheim
Original Assignee
Sound Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sound Pharmaceuticals Inc filed Critical Sound Pharmaceuticals Inc
Publication of PT1056467E publication Critical patent/PT1056467E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99910259T 1998-02-23 1999-02-23 Processo para o tratamento de doencas ou perturbacoes do ouvido interno PT1056467E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19807426A DE19807426A1 (de) 1998-02-23 1998-02-23 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs

Publications (1)

Publication Number Publication Date
PT1056467E true PT1056467E (pt) 2004-02-27

Family

ID=7858563

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99910259T PT1056467E (pt) 1998-02-23 1999-02-23 Processo para o tratamento de doencas ou perturbacoes do ouvido interno

Country Status (11)

Country Link
US (1) US7087581B1 (cg-RX-API-DMAC7.html)
EP (1) EP1056467B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002503687A (cg-RX-API-DMAC7.html)
AT (1) ATE250936T1 (cg-RX-API-DMAC7.html)
AU (1) AU763868B2 (cg-RX-API-DMAC7.html)
CA (1) CA2320717C (cg-RX-API-DMAC7.html)
DE (2) DE19807426A1 (cg-RX-API-DMAC7.html)
DK (1) DK1056467T3 (cg-RX-API-DMAC7.html)
ES (1) ES2211055T3 (cg-RX-API-DMAC7.html)
PT (1) PT1056467E (cg-RX-API-DMAC7.html)
WO (1) WO1999042088A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325198A1 (en) 1999-06-01 2011-05-25 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
EP1307542A2 (en) * 2000-07-11 2003-05-07 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
AU2003268741B2 (en) 2002-10-02 2009-06-11 Anges Mg, Inc. Drug for auditory dysfunction
DE60323876D1 (de) * 2002-12-17 2008-11-13 Centre Nat Rech Scient Verwendung von purinderivaten zur induktion der differenzierung überzähliger haarzellen und deiter-zellen im entwickelnden corti-organ zur behandlung von taubheit
US8431692B2 (en) * 2008-06-06 2013-04-30 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
DE102010007281A1 (de) 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
RU2480195C1 (ru) * 2011-11-02 2013-04-27 Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") Способ лечения заболеваний внутреннего уха
EP2802657B1 (en) 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
US20150079110A1 (en) * 2012-03-05 2015-03-19 Wake Forest University Health Sciences Regeneration of inner ear cells
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
AU727037B2 (en) 1995-11-13 2000-11-30 Cenes Pharmaceuticals, Inc. Methods of treating disorders of non-visual sensory epithelia
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
WO1998000014A1 (en) * 1996-06-28 1998-01-08 The Regents Of The University Of California Transformation and genetherapy of cells of the inner ear
WO1998013048A1 (en) 1996-09-27 1998-04-02 Trustees Of The University Of Pennsylvania Novel methods for inducing proliferation in auditory receptor epithelium
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product

Also Published As

Publication number Publication date
US7087581B1 (en) 2006-08-08
AU763868B2 (en) 2003-07-31
DE19807426A1 (de) 1999-10-14
CA2320717C (en) 2009-03-24
AU2928199A (en) 1999-09-06
EP1056467A2 (de) 2000-12-06
DK1056467T3 (da) 2004-02-09
ATE250936T1 (de) 2003-10-15
ES2211055T3 (es) 2004-07-01
JP2002503687A (ja) 2002-02-05
EP1056467B1 (de) 2003-10-01
DE59907195D1 (de) 2003-11-06
WO1999042088A2 (de) 1999-08-26
CA2320717A1 (en) 1999-08-26
WO1999042088A3 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
PA8478501A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
BR0008958A (pt) Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc
NO20016154D0 (no) Substituerte benzimidazoler
TW200640864A (en) Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
BR9908480A (pt) Compostos heterocìclicos como inibidores de enzimas rotamase
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
ATE311371T1 (de) Nicht-peptide inhibitoren von vla-4 abhängiger zellbindung für die behandlung von entzündungen, autoimmune krankheiten und atemstörungen
NO20021035D0 (no) Fremgangsmåter for anvendelse av rasktvirkende selektive serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
NZ514037A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders
NO20002702L (no) Tienopyrimidiner
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
FI965021A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa
AR028705A1 (es) Bis-arilsulfonas
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
DK1056467T3 (da) Metode til behandling af sygdomme eller lidelser i det indre øre
SE9904765D0 (sv) Pharmaceutically-useful compounds
SE9902267D0 (sv) New compounds
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
NO982863L (no) Nye forbindelser med analgetisk effekt
HK1048439A1 (zh) 用於治疗视神经及视网膜损伤之腺激酶抑制剂
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
NO20055517L (no) 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
ATE361079T1 (de) Verwendung von pyrimidinnukleotiden zur behandlung von schaedigungen des peripheren nervensystems
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet